SARS-CoV-2 pneumonia – Page 4 – Communicable Diseases Research

Duodenal tropism of SARS-CoV-2 and clinical findings in critically ill COVID-19 patients

Original Paper

Published on 2022-02-182022-10-29
Journal: Infection [Category] COVID-19, COVID19(2023년), MERS, SARS, 치료기술,

Evaluation of Muscle Mass and Stiffness with Limb Ultrasound in COVID-19 Survivors

코로나19 생존자의 사지 초음파로 근육량 및 강성 평가

Observational Study

Published on 2022-02-172022-09-12
Journal: Frontiers in Endocrinology [Category] COVID19(2023년), MERS, SARS, 임상, 진단,

Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients

Research

Published on 2022-02-152022-10-31
Journal: The Egyptian Journal of Internal Medicine [Category] COVID-19,

[키워드] acute respiratory distress Analysis ARDS Berlin both group caused Chest Clinical outcome coronavirus Coronavirus disease 2019 Corticosteroid Course COVID-19 COVID-19 pneumonia CRP Cytokine storm D-dimer decrease Dexamethasone diagnosed discharge dose effective effective therapy evaluated ferritin fraction Ground glass opacity ICU inclusion criteria Inflammatory marker intensive care intensive care patient invasive mechanical laboratory result LDH less lymphocyte marker material mechanical ventilation mechanically ventilated mechanically ventilated patient Methylprednisolone methylprednisolone group Mortality neutrophil optimal dose overall mortality oxygen oxygen supplementation P/F ratio Patient patients treated Pneumonia polymerase chain Previous studies prospective cohort study Protein radiological radiological finding required Result SARS-CoV-2 SARS-CoV-2 pneumonia Severe COVID-19 pneumonia severity statistically significant Steroids survival syndrome the patient tomography treated Treatment university were given
[DOI] 10.1186/s43162-022-00113-z PMC 바로가기 [Article Type] Research

SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection

Case Reports

Published on 2022-02-012023-07-07
Journal: Journal of virological methods [Category] COVID19(2023년),

[키워드] Bacterial over-infection myelodysplasia SARS-CoV-2 pneumonia
[DOI] 10.1016/j.jviromet.2021.114419 PMC 바로가기 [Article Type] Case Reports

Lung Function, Radiological Findings and Biomarkers of Fibrogenesis in a Cohort of COVID-19 Patients Six Months After Hospital Discharge

Research article

Published on 2022-02-012022-10-05
Journal: Archivos de bronconeumología [Category] 바이오마커,

[키워드] 6 minute-walk test 6-MWT6 minute-walk test 95% CI 95%CI acute respiratory distress syndrome age ARDSacute respiratory distress syndrome Biomarker BMIbody mass index body mass index change changes in Chest CT Chest radiography chronic obstructive pulmonary disease circulating Computed tomography COPDchronic obstructive pulmonary disease Coronavirus disease 2019 correlation COVID-19 COVID-19coronavirus disease 2019 CT scan CTComputed Tomography diffusing capacity for carbon monoxide diffusion discharge discharged patients DLCOdiffusing capacity for carbon monoxide elevated evaluate Factor female Fibrogenesis finding function functional GGOground-glass opacity Ground glass opacity ground-glass opacity HFNChigh flow nasal cannula oxygen high flow nasal cannula oxygen ILDinterstitial lung disease impairment IMVmechanical ventilation Interstitial lung disease involved lesion lung Lung fibrosis matrix metalloproteinases mechanical ventilation MMP1 MMP7 MMPmatrix metalloproteinases mMRCmodified British Medical Research Council modified British Medical Research Council Month multicenter NIVnon-invasive ventilation non-invasive ventilation parenchymal Patient patients with moderate performed Peripheral blood proportion prospective observational cohort pulmonary pulmonary fibrosis Pulmonary function test radiographic assessment of lung edema radiological radiological abnormality RALEradiographic assessment of lung edema respiratory parameters Result reverse transcriptase-polymerase chain reaction RT-PCRreverse transcriptase-polymerase chain reaction SARS-CoV-2 pneumonia SARS-CoV-2severe acute respiratory syndrome coronavirus 2 SARSSevere Acute Respiratory Syndrome sEGFRsoluble epidermal growth factor receptor serum biomarker serum biomarkers Severe acute respiratory syndrome severe acute respiratory syndrome coronavirus 2 Severe COVID-19 pneumonia severe patients Sex soluble epidermal growth factor receptor Survivors vascular endothelial growth factor VEGFvascular endothelial growth factor
[DOI] 10.1016/j.arbres.2021.08.014 [Article Type] Research article

Disseminated histoplasmosis in an immunocompetent patient with COVID-19 pneumonia

COVID-19 폐렴에 걸린 면역 적격 환자의 파종성 히스토플라스마증

Case Reports

Published on 2022-01-212022-09-11
Journal: BMJ case reports [Category] SARS, 치료기술,

[키워드] adult intensive care AIDS Amphotericin amphotericin B Awareness Bacterial infections Coinfection COVID-19 COVID-19 pneumonia Critically ill death Diagnosis differential diagnosis distress extubation fungal fungal pathogen fungal pathogens Histoplasmosis immunosuppressive condition immunosuppressive conditions Infectious disease Infectious diseases Intensive intensive care intensive care unit Invasive mechanical ventilation itraconazole mechanical ventilation on mechanical ventilation other respiratory infections Pathogens Patient patient with COVID-19 Pneumonia pneumonia (infectious disease) Prevent reduce remained required respiratory distress Respiratory distress syndrome Respiratory failure respiratory infections SARS-CoV-2 pneumonia secondary to syndrome TB and other respiratory infections the patient therapy transfer Treatment weaning worsening respiratory failure
[DOI] 10.1136/bcr-2021-247617 PMC 바로가기 [Article Type] Case Reports

Effectiveness of low-dose radiation therapy in COVID-19 patients globally: A systematic review

전 세계적으로 코로나19 환자에서 저선량 방사선 요법의 효과: 체계적인 검토

Clinical Trial

Published on 2022-01-192022-09-11
Journal: F1000Research [Category] SARS, 임상,

[키워드] Affect article baseline benefit Case-control change CINAHL Clinical course Cohort Combination conducted confounding effect Corona COVID pneumonia COVID-19 COVID-19 patients COVID-19 pneumonia Cross-sectional studies cross-sectional study CT-scan Cytokines defined demonstrated double-blind double-blind randomized controlled trial drug drugs duplicates Google Scholar High-dose IL-1a inclusion criteria Inflammatory inflammatory disease inflammatory markers interleukin Intervention item LDRT leukocyte low-dose Low-dose radiation therapy Lungs meta-analyses Mortality multiple organs no effect novel other diseases participant Patient Pneumonia proinflammatory proinflammatory cytokines Radiation radiation therapy Radiotherapy Randomized receiving recruitment reduce Reporting Research resulting SARS-CoV-2 pneumonia status steroid Steroids Support systematic review therapy treat treated Virus Disease was used were excluded
[DOI] 10.12688/f1000research.74558.1 PMC 바로가기 [Article Type] Clinical Trial

Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia

Medicine

Published on 2022-01-102022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] “cytokine storm” acute respiratory distress syndrome (ARDS) All the patient analyzed benefit Berlin C-reactive protein Case series clinical response clinically coronavirus 2019 disease COVID-19 Critically ill patient cytokine cytokine removal D-dimer death dysregulated Europe evaluate failure ferritin Germany hemoadsorption high risk hypercytokinemia ICU identifying IL-6 Ill improvement in-hospital mortality inflammatory biomarkers Inflammatory response intensive care interleukin-6 Invasive mechanical ventilation organ dysfunction Oxygenation PaO pathophysiology Patient plasma Prone position prone positioning reduction in rescue respiratory Respiratory failure Retrospective study SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 pneumonia severe respiratory failure significant difference single center SOFA score Therapies therapy Treatment with COVID-19
[DOI] 10.3389/fmed.2021.779038 PMC 바로가기 [Article Type] Medicine

Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study

Research

Published on 2022-01-042022-11-01
Journal: Critical Care [Category] COVID-19,

[키워드] 28-day mortality 95% CI Analysis Aspergillus Blot clinical Cohort cohort study competing COVID-19 Critically ill cumulative dead determine European hazard ratio ICU incidence Influenza influenza pneumonia intensive care unit intubated patient invasive Invasive mechanical ventilation Invasive pulmonary aspergillosis IPA mechanical ventilation multicenter objective Patient patients patients with SARS-CoV-2 Pneumonia Primary outcome recent Registered respiratory tract Result retrospective risk factor SARS-CoV-2 SARS-CoV-2 patients SARS-CoV-2 pneumonia severe influenza significant increase significantly lower study population supplementary material the SARS-CoV-2 Trial registration
[DOI] 10.1186/s13054-021-03874-1 PMC 바로가기 [Article Type] Research

Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study

SARS-CoV-2 폐렴 환자에 대한 토실리주맙 또는 글루코코르티코이드 치료: 관찰 연구

Observational Study

Published on 2022-01-012022-09-12
Journal: The Brazilian journal of infectious diseases : an [Category] SARS, 임상, 진단,